<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32987860</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>High-Throughput Genetic Testing in ALS: The Challenging Path of Variant Classification Considering the ACMG Guidelines.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1123</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes11101123</ELocationID><Abstract><AbstractText>The development of high-throughput sequencing technologies and screening of big patient cohorts with familial and sporadic amyotrophic lateral sclerosis (ALS) led to the identification of a significant number of genetic variants, which are sometimes difficult to interpret. The American College of Medical Genetics and Genomics (ACMG) provided guidelines to help molecular geneticists and pathologists to interpret variants found in laboratory testing. We assessed the application of the ACMG criteria to ALS-related variants, combining data from literature with our experience. We analyzed a cohort of 498 ALS patients using massive parallel sequencing of ALS-associated genes and identified 280 variants with a minor allele frequency &lt; 1%. Examining all variants using the ACMG criteria, thus considering the type of variant, inheritance, familial segregation, and possible functional studies, we classified 20 variants as "pathogenic". In conclusion, ALS's genetic complexity, such as oligogenic inheritance, presence of genes acting as risk factors, and reduced penetrance, needs to be considered when interpreting variants. The goal of this work is to provide helpful suggestions to geneticists and clinicians dealing with ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lattante</LastName><ForeName>Serena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2891-0340</Identifier><AffiliationInfo><Affiliation>Section of Genomic Medicine, Department of Life Sciences and Public Health, Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Complex Operational Unit of Medical Genetics, Department of Laboratory and Infectious Disease Sciences, A. Gemelli University Hospital Foundation IRCCS, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marangi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-6898-8882</Identifier><AffiliationInfo><Affiliation>Section of Genomic Medicine, Department of Life Sciences and Public Health, Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Complex Operational Unit of Medical Genetics, Department of Laboratory and Infectious Disease Sciences, A. Gemelli University Hospital Foundation IRCCS, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doronzio</LastName><ForeName>Paolo Niccol&#xf2;</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Section of Genomic Medicine, Department of Life Sciences and Public Health, Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Complex Operational Unit of Medical Genetics, Department of Laboratory and Infectious Disease Sciences, A. Gemelli University Hospital Foundation IRCCS, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conte</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Adult NEMO Clinical Center, Complex Operational Unit of Neurology, Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, A. Gemelli University Hospital Foundation IRCCS, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bisogni</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Adult NEMO Clinical Center, Complex Operational Unit of Neurology, Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, A. Gemelli University Hospital Foundation IRCCS, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zollino</LastName><ForeName>Marcella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Section of Genomic Medicine, Department of Life Sciences and Public Health, Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Complex Operational Unit of Medical Genetics, Department of Laboratory and Infectious Disease Sciences, A. Gemelli University Hospital Foundation IRCCS, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabatelli</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Adult NEMO Clinical Center, Complex Operational Unit of Neurology, Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, A. Gemelli University Hospital Foundation IRCCS, 00168 Roma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Neurology, Department of Neuroscience, Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="Y">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005826" MajorTopicYN="N">Genetics, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015894" MajorTopicYN="Y">Genome, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACMG guidelines</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">gene panel sequencing</Keyword><Keyword MajorTopicYN="N">high-throughput genetic testing</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32987860</ArticleId><ArticleId IdType="pmc">PMC7600768</ArticleId><ArticleId IdType="doi">10.3390/genes11101123</ArticleId><ArticleId IdType="pii">genes11101123</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Battistini S., Calvo A., Caponnetto C., Conforti F.L., Corbo M., Giannini F., Mandrioli J., Mora G., Sabatelli M., et al. Genetic counselling in ALS: Facts, uncertainties and clinical suggestions. J. Neurol. Neurosurg. Psychiatry. 2014;85:478&#x2013;485. doi: 10.1136/jnnp-2013-305546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-305546</ArticleId><ArticleId IdType="pubmed">23833266</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405&#x2013;423. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.-J., Li H.-F., Tan G.-H., Tao Q.-Q., Ni W., Cheng X.-W., Xiong Z.-Q., Wu Z.-Y. Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system. Neurobiol. Aging. 2014;35:2881.e11&#x2013;2881.e15. doi: 10.1016/j.neurobiolaging.2014.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.003</ArticleId><ArticleId IdType="pubmed">25109764</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensato V., Magri S., Dalla Bella E., Tannorella P., Bersano E., Sorar&#xf9; G., Gatti M., Ticozzi N., Taroni F., Lauria G., et al. Sorting Rare ALS Genetic Variants by Targeted Re-Sequencing Panel in Italian Patients: OPTN, VCP, and SQSTM1 Variants Account for 3% of Rare Genetic Forms. J. Clin. Med. 2020;9:412. doi: 10.3390/jcm9020412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020412</ArticleId><ArticleId IdType="pmc">PMC7073901</ArticleId><ArticleId IdType="pubmed">32028661</ArticleId></ArticleIdList></Reference><Reference><Citation>Roggenbuck J., Palettas M., Vicini L., Patel R., Quick A., Kolb S.J. Incidence of pathogenic, likely pathogenic, and uncertain ALS variants in a clinic cohort. Neurol. Genet. 2020;6:e390. doi: 10.1212/NXG.0000000000000390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000390</ArticleId><ArticleId IdType="pmc">PMC6984133</ArticleId><ArticleId IdType="pubmed">32042918</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A., Drory V., Hardiman O., Nakano I., Ravits J., Robberecht W., Shefner J. A revision of the El Escorial criteria-2015. Amyotroph. Lateral Scler. Front. Degener. 2015;16:291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Li M., Hakonarson H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164. doi: 10.1093/nar/gkq603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq603</ArticleId><ArticleId IdType="pmc">PMC2938201</ArticleId><ArticleId IdType="pubmed">20601685</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian X., Boerwinkle E., Liu X. In silico prediction of splice-altering single nucleotide variants in the human genome. Nucleic Acids Res. 2014;42:13534&#x2013;13544. doi: 10.1093/nar/gku1206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1206</ArticleId><ArticleId IdType="pmc">PMC4267638</ArticleId><ArticleId IdType="pubmed">25416802</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Jian X., Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Hum. Mutat. 2011;32:894&#x2013;899. doi: 10.1002/humu.21517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21517</ArticleId><ArticleId IdType="pmc">PMC3145015</ArticleId><ArticleId IdType="pubmed">21520341</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Wu C., Li C., Boerwinkle E. dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs. Hum. Mutat. 2016;37:235&#x2013;241. doi: 10.1002/humu.22932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22932</ArticleId><ArticleId IdType="pmc">PMC4752381</ArticleId><ArticleId IdType="pubmed">26555599</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Wang K. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am. J. Hum. Genet. 2017;100:267&#x2013;280. doi: 10.1016/j.ajhg.2017.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2017.01.004</ArticleId><ArticleId IdType="pmc">PMC5294755</ArticleId><ArticleId IdType="pubmed">28132688</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Conte A., Zollino M., Luigetti M., Del Grande A., Marangi G., Romano A., Marcaccio A., Meleo E., Bisogni G., et al. Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology. 2012;79:66&#x2013;72. doi: 10.1212/WNL.0b013e31825dceca.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31825dceca</ArticleId><ArticleId IdType="pubmed">22722621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Pomponi M.G., Conte A., Marangi G., Bisogni G., Patanella A.K., Meleo E., Lunetta C., Riva N., Mosca L., et al. ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis. Neurobiol. Aging. 2018;64:157.e1&#x2013;157.e5. doi: 10.1016/j.neurobiolaging.2017.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.11.011</ArticleId><ArticleId IdType="pubmed">29274668</ArticleId></ArticleIdList></Reference><Reference><Citation>Project MinE ALS Sequencing Consortium CHCHD10 variants in amyotrophic lateral sclerosis: Where is the evidence? Ann. Neurol. 2018;84:110&#x2013;116. doi: 10.1002/ana.25273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25273</ArticleId><ArticleId IdType="pmc">PMC6553489</ArticleId><ArticleId IdType="pubmed">30014597</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K.P., Renton A.E., Ticozzi N., Faghri F., Chia R., Dominov J.A., Kenna B.J., Nalls M.A., Keagle P., et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 2018;97:1268&#x2013;1283.e6. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W., Shatunov A., Dekker A.M., McLaughlin R.L., Diekstra F.P., Pulit S.L., van der Spek R.A.A., V&#xf5;sa U., de Jong S., Robinson M.R., et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Jiang H., Wang F., Li S., Wu C., Bao J., Zhu Y., Xu Z., Liu B., Ren H., et al. UNC13A variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: A meta-analysis. Neurol. Sci. 2019;40:2293&#x2013;2302. doi: 10.1007/s10072-019-03951-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03951-y</ArticleId><ArticleId IdType="pubmed">31201598</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan H.H.G., Westeneng H., Burgh H.K., Es M.A., Bakker L.A., Veenhuijzen K., Eijk K.R., Eijk R.P.A., Veldink J.H., Berg L.H. The Distinct Traits of the UNC13A Polymorphism in Amyotrophic Lateral Sclerosis. Ann. Neurol. 2020;88:796&#x2013;806. doi: 10.1002/ana.25841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25841</ArticleId><ArticleId IdType="pmc">PMC7540607</ArticleId><ArticleId IdType="pubmed">32627229</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagi K.S., Wu Z., Amaya J., Chapkis N., Duffy A.M., Hajdarovic K.H., Held A., Mathur A.D., Russo K., Ryan V.H., et al. Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral Sclerosis. Neuroscience. 2019;396:A3&#x2013;A20. doi: 10.1016/j.neuroscience.2018.10.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.10.033</ArticleId><ArticleId IdType="pmc">PMC6549511</ArticleId><ArticleId IdType="pubmed">30594291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Marangi G., Conte A., Tasca G., Zollino M., Lattante S. New ALS-Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis. Brain Pathol. 2016;26:266&#x2013;275. doi: 10.1111/bpa.12354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12354</ArticleId><ArticleId IdType="pubmed">26780671</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon Y.A., Fratta P., Traynor B.J., Chia R. The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci. 2020;14:42. doi: 10.3389/fnins.2020.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00042</ArticleId><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M., Wuu J., Fernandez C., Weihl C.C., Katzen H., Steele J., Oskarsson B., Taylor J.P. Motor neuron involvement in multisystem proteinopathy: Implications for ALS. Neurology. 2013;80:1874&#x2013;1880. doi: 10.1212/WNL.0b013e3182929fc3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182929fc3</ArticleId><ArticleId IdType="pmc">PMC3908355</ArticleId><ArticleId IdType="pubmed">23635965</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaie T. Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin. Science. 2002;295:1077&#x2013;1079. doi: 10.1126/science.1066901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1066901</ArticleId><ArticleId IdType="pubmed">11834836</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel C., Kessler K., Giessl A., Dimmler A., Shalev S.A., von der Haar S., Zenker M., Zahnleiter D., St&#xf6;ss H., Beinder E., et al. NEK1 Mutations Cause Short-Rib Polydactyly Syndrome Type Majewski. Am. J. Hum. Genet. 2011;88:106&#x2013;114. doi: 10.1016/j.ajhg.2010.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2010.12.004</ArticleId><ArticleId IdType="pmc">PMC3014367</ArticleId><ArticleId IdType="pubmed">21211617</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecoraro V., Mandrioli J., Carone C., Chi&#xf2; A., Traynor B.J., Trenti T. The NGS technology for the identification of genes associated with the ALS. A systematic review. Eur. J. Clin. Investig. 2020;50:e13228. doi: 10.1111/eci.13228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13228</ArticleId><ArticleId IdType="pubmed">32293029</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoecke A., Schoonaert L., Lemmens R., Timmers M., Staats K.A., Laird A.S., Peeters E., Philips T., Goris A., Dubois B., et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat. Med. 2012;18:1418&#x2013;1422. doi: 10.1038/nm.2901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2901</ArticleId><ArticleId IdType="pubmed">22922411</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.-X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S., Yanagisawa Y., Skaug J., Fichter K., Nasir J., Martindale D., Koop B.F., Scherer S.W., Nicholson D.W., Rouleau G.A., et al. Cloning and Characterization of Three Novel Genes, ALS2CR1, ALS2CR2, and ALS2CR3, in the Juvenile Amyotrophic Lateral Sclerosis (ALS2) Critical Region at Chromosome 2q33&#x2013;q34: Candidate Genes for ALS2. Genomics. 2001;71:200&#x2013;213. doi: 10.1006/geno.2000.6392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/geno.2000.6392</ArticleId><ArticleId IdType="pubmed">11161814</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-Z., Bennett C.L., Huynh H.M., Blair I.P., Puls I., Irobi J., Dierick I., Abel A., Kennerson M.L., Rabin B.A., et al. DNA/RNA Helicase Gene Mutations in a Form of Juvenile Amyotrophic Lateral Sclerosis (ALS4) Am. J. Hum. Genet. 2004;74:1128&#x2013;1135. doi: 10.1086/421054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421054</ArticleId><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlacchio A., Babalini C., Borreca A., Patrono C., Massa R., Basaran S., Munhoz R.P., Rogaeva E.A., St George-Hyslop P.H., Bernardi G., et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133:591&#x2013;598. doi: 10.1093/brain/awp325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp325</ArticleId><ArticleId IdType="pmc">PMC2822627</ArticleId><ArticleId IdType="pubmed">20110243</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H., Zhou S., Noreau A., Sabbagh M., Belzil V., Dionne-Laporte A., Tranchant C., Dion P., Rouleau G.A. Exome sequencing reveals SPG11 mutations causing juvenile ALS. Neurobiol. Aging. 2012;33:839.e5&#x2013;839.e9. doi: 10.1016/j.neurobiolaging.2011.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.11.012</ArticleId><ArticleId IdType="pubmed">22154821</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D.A., LeClerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Mitne-Neto M., Silva H.C.A., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R.M., Gillingwater T., Webb J., et al. A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis. Am. J. Hum. Genet. 2004;75:822&#x2013;831. doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., et al. ANG mutations segregate with familial and &#x201c;sporadic&#x201d; amyotrophic lateral sclerosis. Nat. Genet. 2006;38:411&#x2013;413. doi: 10.1038/ng1742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1742</ArticleId><ArticleId IdType="pubmed">16501576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Velde C.V., Bouchard J.-P., Lacomblez L., Pochigaeva K., Salachas F., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow C.Y., Landers J.E., Bergren S.K., Sapp P.C., Grant A.E., Jones J.M., Everett L., Lenk G.M., McKenna-Yasek D.M., Weisman L.S., et al. Deleterious Variants of FIG4, a Phosphoinositide Phosphatase, in Patients with ALS. Am. J. Hum. Genet. 2009;84:85&#x2013;88. doi: 10.1016/j.ajhg.2008.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.12.010</ArticleId><ArticleId IdType="pmc">PMC2668033</ArticleId><ArticleId IdType="pubmed">19118816</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.-X., Chen W., Hong S.-T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A., Al-Mohanna F., Bohlega S. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 2011;70:913&#x2013;919. doi: 10.1002/ana.22534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pubmed">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson N., Ince P.G., Smith M.O., Highley R., Skibinski G., Andersen P.M., Morrison K.E., Pall H.S., Hardiman O., Collinge J., et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B) Neurology. 2006;67:1074&#x2013;1077. doi: 10.1212/01.wnl.0000231510.89311.8b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000231510.89311.8b</ArticleId><ArticleId IdType="pubmed">16807408</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.-H., Fallini C., Ticozzi N., Keagle P.J., Sapp P.C., Piotrowska K., Lowe P., Koppers M., McKenna-Yasek D., Baron D.M., et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488:499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y., Fukuda Y., Yoshimura J., Toyoda A., Kurppa K., Moritoyo H., Belzil V.V., Dion P.A., Higasa K., Doi K., et al. ERBB4 Mutations that Disrupt the Neuregulin-ErbB4 Pathway Cause Amyotrophic Lateral Sclerosis Type 19. Am. J. Hum. Genet. 2013;93:900&#x2013;905. doi: 10.1016/j.ajhg.2013.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.09.008</ArticleId><ArticleId IdType="pmc">PMC3824132</ArticleId><ArticleId IdType="pubmed">24119685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim N.C., Wang Y.-D., Scarborough E.A., Moore J., Diaz Z., MacLea K.S., Freibaum B., Li S., Molliex A., et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Pioro E.P., Boehringer A., Chia R., Feit H., Renton A.E., Pliner H.A., Abramzon Y., Marangi G., Winborn B.J., et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 2014;17:664&#x2013;666. doi: 10.1038/nn.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3688</ArticleId><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B.N., Ticozzi N., Fallini C., Gkazi A.S., Topp S., Kenna K.P., Scotter E.L., Kost J., Keagle P., Miller J.W., et al. Exome-wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS. Neuron. 2014;84:324&#x2013;331. doi: 10.1016/j.neuron.2014.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.09.027</ArticleId><ArticleId IdType="pmc">PMC4521390</ArticleId><ArticleId IdType="pubmed">25374358</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B.N., Topp S.D., Fallini C., Shibata H., Chen H.-J., Troakes C., King A., Ticozzi N., Kenna K.P., Soragia-Gkazi A., et al. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci. Transl. Med. 2017;9:eaad9157. doi: 10.1126/scitranslmed.aad9157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aad9157</ArticleId><ArticleId IdType="pmc">PMC6599403</ArticleId><ArticleId IdType="pubmed">28469040</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., M&#xfc;ller K., Wieland T., Weydt P., B&#xf6;hm S., Lul&#xe9; D., H&#xfc;bers A., Neuwirth C., Weber M., Borck G., et al. NEK1 mutations in familial amyotrophic lateral sclerosis. Brain. 2016;139:e28. doi: 10.1093/brain/aww033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww033</ArticleId><ArticleId IdType="pubmed">26945885</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna K.P., van Doormaal P.T.C., Dekker A.M., Ticozzi N., Kenna B.J., Diekstra F.P., van Rheenen W., van Eijk K.R., Jones A.R., Keagle P., et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1037&#x2013;1042. doi: 10.1038/ng.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., Yilmaz R., M&#xfc;ller K., Grehl T., Petri S., Meyer T., Grosskreutz J., Weydt P., Ruf W., Neuwirth C., et al. Hot-spot KIF5A mutations cause familial ALS. Brain. 2018;141:688&#x2013;697. doi: 10.1093/brain/awx370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx370</ArticleId><ArticleId IdType="pmc">PMC5837483</ArticleId><ArticleId IdType="pubmed">29342275</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S., Ait-El-Mkadem S., Chaussenot A., Genin E.C., Lacas-Gervais S., Fragaki K., Berg-Alonso L., Kageyama Y., Serre V., Moore D.G., et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137:2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F., Yan J., Pavan Vemula S., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., et al. SQSTM1 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Arch. Neurol. 2011;68:1440. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., M&#xfc;ller K., Marroquin N., Nordin F., H&#xfc;bers A., Weydt P., et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.-F., Wang Q., Krueger B.J., et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K.L., Topp S., Yang S., Smith B., Fifita J.A., Warraich S.T., Zhang K.Y., Farrawell N., Vance C., Hu X., et al. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat. Commun. 2016;7:11253. doi: 10.1038/ncomms11253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11253</ArticleId><ArticleId IdType="pmc">PMC4835537</ArticleId><ArticleId IdType="pubmed">27080313</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R., Kousi M., Farhan S.M.K., Willer J.R., Ross J.P., Dion P.A., Rouleau G.A., Daly M.J., Neale B.M., La Bella V., et al. Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion. Hum. Genom. 2019;13:19. doi: 10.1186/s40246-019-0203-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-019-0203-9</ArticleId><ArticleId IdType="pmc">PMC6469102</ArticleId><ArticleId IdType="pubmed">30992063</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun Y., Hong S.-A., Kim K.-K., Baek D., Lee D., Londhe A.M., Lee M., Yu J., McEachin Z.T., Bassell G.J., et al. CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individual. Commun. Biol. 2020;3:33. doi: 10.1038/s42003-020-0755-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-020-0755-1</ArticleId><ArticleId IdType="pmc">PMC6970999</ArticleId><ArticleId IdType="pubmed">31959876</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., M&#xfc;ller K., Gastl R., Gorges M., Otto M., Pinkhardt E.H., Kassubek J., Weishaupt J.H., Ludolph A.C. Analysis of CACNA1A CAG repeat lengths in patients with familial ALS. Neurobiol. Aging. 2019;74:235.e5&#x2013;235.e8. doi: 10.1016/j.neurobiolaging.2018.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.09.019</ArticleId><ArticleId IdType="pubmed">30342765</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T., Li Y.R., Chesi A., Hart M.P., Ramos D., Jethava N., Hosangadi D., Epstein J., Hodges B., Bonini N.M., et al. Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology. 2011;76:2062&#x2013;2065. doi: 10.1212/WNL.0b013e31821f4447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821f4447</ArticleId><ArticleId IdType="pmc">PMC3111240</ArticleId><ArticleId IdType="pubmed">21562248</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson-Stone C., Hallupp M., Shahheydari H., Ragagnin A.M.G., Chatterton Z., Carew-Jones F., Shepherd C.E., Stefen H., Paric E., Fath T., et al. CYLD is a causative gene for frontotemporal dementia&#x2013;amyotrophic lateral sclerosis. Brain. 2020;143:783&#x2013;799. doi: 10.1093/brain/awaa039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa039</ArticleId><ArticleId IdType="pmc">PMC7089666</ArticleId><ArticleId IdType="pubmed">32185393</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J., Paul P., Chen H.-J., Morris A., Payling M., Falchi M., Habgood J., Panoutsou S., Winkler S., Tisato V., et al. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc. Natl. Acad. Sci. USA. 2010;107:7556&#x2013;7561. doi: 10.1073/pnas.0914128107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0914128107</ArticleId><ArticleId IdType="pmc">PMC2867752</ArticleId><ArticleId IdType="pubmed">20368421</ArticleId></ArticleIdList></Reference><Reference><Citation>Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L.F., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., et al. Mutant dynactin in motor neuron disease. Nat. Genet. 2003;33:455&#x2013;456. doi: 10.1038/ng1123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1123</ArticleId><ArticleId IdType="pubmed">12627231</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhan S.M.K., Howrigan D.P., Abbott L.E., Klim J.R., Topp S.D., Byrnes A.E., Churchhouse C., Phatnani H., Smith B.N., Rampersaud E., et al. Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. Nat. Neurosci. 2019;22:1966&#x2013;1974. doi: 10.1038/s41593-019-0530-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0530-0</ArticleId><ArticleId IdType="pmc">PMC6919277</ArticleId><ArticleId IdType="pubmed">31768050</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunca C., Ak&#xe7;imen F., Co&#x15f;kun C., G&#xfc;ndo&#x11f;du-Eken A., Kocoglu C., &#xc7;evik B., Bekircan-Kurt C.E., Tan E., Ba&#x15f;ak A.N. ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree. Eur. J. Hum. Genet. 2018;26:745&#x2013;748. doi: 10.1038/s41431-018-0107-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0107-5</ArticleId><ArticleId IdType="pmc">PMC5945623</ArticleId><ArticleId IdType="pubmed">29453415</ArticleId></ArticleIdList></Reference><Reference><Citation>Amador M.-D.-M., Muratet F., Teyssou E., Banneau G., Danel-Brunaud V., Allart E., Antoine J.-C., Camdessanch&#xe9; J.-P., Anheim M., Rudolf G., et al. Spastic paraplegia due to recessive or dominant mutations in ERLIN2 can convert to ALS. Neurol. Genet. 2019;5:e374. doi: 10.1212/NXG.0000000000000374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000374</ArticleId><ArticleId IdType="pmc">PMC6927358</ArticleId><ArticleId IdType="pubmed">32042907</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J., Hart M.P., Erion R., King O.D., Diaz Z., Nakaya T., Ibrahim F., Kim H.-J., Mojsilovic-Petrovic J., Panossian S., et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012;21:2899&#x2013;2911. doi: 10.1093/hmg/dds116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds116</ArticleId><ArticleId IdType="pmc">PMC3373238</ArticleId><ArticleId IdType="pubmed">22454397</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Brulard C., Beltran S., Marouillat S., Bakkouche S.E., Andres C.R., Blasco H., Vourc&#x2019;h P. Typical bulbar ALS can be linked to GARS mutation. Amyotroph. Lateral Scler. Front. Degener. 2019;20:275&#x2013;277. doi: 10.1080/21678421.2018.1556699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1556699</ArticleId><ArticleId IdType="pubmed">30661401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneb H.M., Folkmann A.W., Belzil V.V., Jao L.-E., Leblond C.S., Girard S.L., Daoud H., Noreau A., Rochefort D., Hince P., et al. Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2015;24:1363&#x2013;1373. doi: 10.1093/hmg/ddu545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu545</ArticleId><ArticleId IdType="pmc">PMC4321443</ArticleId><ArticleId IdType="pubmed">25343993</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Moll T., Ramesh T., Castelli L., Beer A., Robins H., Fox I., Niedermoser I., Van Damme P., Moisse M., et al. Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral Sclerosis. Cell Rep. 2019;26:2298&#x2013;2306.e5. doi: 10.1016/j.celrep.2019.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.02.006</ArticleId><ArticleId IdType="pmc">PMC7003067</ArticleId><ArticleId IdType="pubmed">30811981</ArticleId></ArticleIdList></Reference><Reference><Citation>Schymick J.C., Yang Y., Andersen P.M., Vonsattel J.P., Greenway M., Momeni P., Elder J., Chio A., Restagno G., Robberecht W., et al. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J. Neurol. Neurosurg. Psychiatry. 2006;78:754&#x2013;756. doi: 10.1136/jnnp.2006.109553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.109553</ArticleId><ArticleId IdType="pmc">PMC2117704</ArticleId><ArticleId IdType="pubmed">17371905</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Al-Chalabi A., Ruddy D., Smith B.N., Hu X., Sreedharan J., Siddique T., Schelhaas H.J., Kusters B., Troost D., et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2&#x2013;21.3. Brain. 2006;129:868&#x2013;876. doi: 10.1093/brain/awl030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl030</ArticleId><ArticleId IdType="pubmed">16495328</ArticleId></ArticleIdList></Reference><Reference><Citation>Figlewicz D.A., Krizus A., Martinoli M.G., Meininger V., Dib M., Rouleau G.A., Julien J.-P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 1994;3:1757&#x2013;1761. doi: 10.1093/hmg/3.10.1757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/3.10.1757</ArticleId><ArticleId IdType="pubmed">7849698</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Mol. Genet. 1999;8:157&#x2013;164. doi: 10.1093/hmg/8.2.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/8.2.157</ArticleId><ArticleId IdType="pubmed">9931323</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung C.L., He C.Z., Kaufmann P., Chin S.S., Naini A., Liem R.K.H., Mitsumoto H., Hays A.P. A Pathogenic Peripherin Gene Mutation in a Patient with Amyotrophic Lateral Sclerosis. Brain Pathol. 2006;14:290&#x2013;296. doi: 10.1111/j.1750-3639.2004.tb00066.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2004.tb00066.x</ArticleId><ArticleId IdType="pubmed">15446584</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo K., Lim S.M., Nahm M., Kim Y.-E., Oh K.-W., Park H.T., Ki C.-S., Kim S.H., Lee S. A De Novo RAPGEF2 Variant Identified in a Sporadic Amyotrophic Lateral Sclerosis Patient Impairs Microtubule Stability and Axonal Mitochondria Distribution. Exp. Neurobiol. 2018;27:550&#x2013;563. doi: 10.5607/en.2018.27.6.550.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2018.27.6.550</ArticleId><ArticleId IdType="pmc">PMC6318558</ArticleId><ArticleId IdType="pubmed">30636905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger S., Battke F., Sprecher A., Munz M., Synofzik M., Sch&#xf6;ls L., Gasser T., Grehl T., Prudlo J., Biskup S. Rare Variants in Neurodegeneration Associated Genes Revealed by Targeted Panel Sequencing in a German ALS Cohort. Front. Mol. Neurosci. 2016;9:92. doi: 10.3389/fnmol.2016.00092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00092</ArticleId><ArticleId IdType="pmc">PMC5061735</ArticleId><ArticleId IdType="pubmed">27790088</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanovic A., Widjaja M., F&#xf6;rster A., Weder J., Wattjes M.P., Lange I., Sarikidi A., Auber B., Raab P., Christians A., et al. SPG7 mutations in amyotrophic lateral sclerosis: A genetic link to hereditary spastic paraplegia. J. Neurol. 2020;267:2732&#x2013;2743. doi: 10.1007/s00415-020-09861-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09861-w</ArticleId><ArticleId IdType="pmc">PMC7419373</ArticleId><ArticleId IdType="pubmed">32447552</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesi A., Staahl B.T., Jovi&#x10d;i&#x107; A., Couthouis J., Fasolino M., Raphael A.R., Yamazaki T., Elias L., Polak M., Kelly C., et al. Exome sequencing to identify de novo mutations in sporadic ALS trios. Nat. Neurosci. 2013;16:851&#x2013;855. doi: 10.1038/nn.3412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3412</ArticleId><ArticleId IdType="pmc">PMC3709464</ArticleId><ArticleId IdType="pubmed">23708140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N., Vance C., LeClerc A.L., Keagle P., Glass J.D., McKenna-Yasek D., Sapp P.C., Silani V., Bosco D.A., Shaw C.E., et al. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2011;156:285&#x2013;290. doi: 10.1002/ajmg.b.31158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.31158</ArticleId><ArticleId IdType="pubmed">21438137</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Nicholson A.M., Sarkar M., Messing J., Purice M.D., Pottier C., Annu K., Baker M., Perkerson R.B., Kurti A., et al. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron. 2017;95:808&#x2013;816.e9. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski K.J., Francioli L.C., Tiao G., Cummings B.B., Alf&#xf6;ldi J., Wang Q., Collins R.L., Laricchia K.M., Ganna A., Birnbaum D.P., et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434&#x2013;443. doi: 10.1038/s41586-020-2308-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2308-7</ArticleId><ArticleId IdType="pmc">PMC7334197</ArticleId><ArticleId IdType="pubmed">32461654</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui R., Tuo M., Li P., Zhou C. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: A meta-analysis. Neurol. Sci. 2018;39:811&#x2013;820. doi: 10.1007/s10072-018-3246-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3246-0</ArticleId><ArticleId IdType="pubmed">29349657</ArticleId></ArticleIdList></Reference><Reference><Citation>de Majo M., Topp S.D., Smith B.N., Nishimura A.L., Chen H.-J., Gkazi A.S., Miller J., Wong C.H., Vance C., Baas F., et al. ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function. Neurobiol. Aging. 2018;71:266.e1&#x2013;266.e10. doi: 10.1016/j.neurobiolaging.2018.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.06.015</ArticleId><ArticleId IdType="pmc">PMC6983933</ArticleId><ArticleId IdType="pubmed">30033073</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.-E., Oh K.-W., Noh M.-Y., Nahm M., Park J., Lim S.M., Jang J.-H., Cho E.-H., Ki C.-S., Lee S., et al. Genetic and functional analysis of TBK1 variants in Korean patients with sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2017;50:170.e1&#x2013;170.e6. doi: 10.1016/j.neurobiolaging.2016.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.11.003</ArticleId><ArticleId IdType="pubmed">27939697</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S., Che C., Feng S., Liu C., Li L., Li Y., Huang H., Zou Z. Novel mutation in optineurin causing aggressive ALS+/&#x2212;frontotemporal dementia. Ann. Clin. Transl. Neurol. 2019;6:2377&#x2013;2383. doi: 10.1002/acn3.50928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50928</ArticleId><ArticleId IdType="pmc">PMC6917321</ArticleId><ArticleId IdType="pubmed">31838784</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz R., M&#xfc;ller K., Brenner D., Volk A.E., Borck G., Hermann A., Meitinger T., Strom T.M., Danzer K.M., Ludolph A.C., et al. SQSTM1/p62 variants in 486 patients with familial ALS from Germany and Sweden. Neurobiol. Aging. 2020;87:139.e9&#x2013;139.e15. doi: 10.1016/j.neurobiolaging.2019.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.10.018</ArticleId><ArticleId IdType="pubmed">31859009</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E., Takeda T., Lebon V., Boill&#xe9;e S., Doukour&#xe9; B., Bataillon G., Sazdovitch V., Cazeneuve C., Meininger V., LeGuern E., et al. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: Genetics and neuropathology. Acta Neuropathol. 2013;125:511&#x2013;522. doi: 10.1007/s00401-013-1090-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1090-0</ArticleId><ArticleId IdType="pubmed">23417734</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso N., Calero-Paniagua I., del Pino-Montes J. Clinical and Genetic Advances in Paget&#x2019;s Disease of Bone: A Review. Clin. Rev. Bone Miner. Metab. 2017;15:37&#x2013;48. doi: 10.1007/s12018-016-9226-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12018-016-9226-0</ArticleId><ArticleId IdType="pmc">PMC5309316</ArticleId><ArticleId IdType="pubmed">28255281</ArticleId></ArticleIdList></Reference><Reference><Citation>Haack T.B., Ignatius E., Calvo-Garrido J., Iuso A., Isohanni P., Maffezzini C., L&#xf6;nnqvist T., Suomalainen A., Gorza M., Kremer L.S., et al. Absence of the Autophagy Adaptor SQSTM1/p62 Causes Childhood-Onset Neurodegeneration with Ataxia, Dystonia, and Gaze Palsy. Am. J. Hum. Genet. 2016;99:735&#x2013;743. doi: 10.1016/j.ajhg.2016.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2016.06.026</ArticleId><ArticleId IdType="pmc">PMC5010644</ArticleId><ArticleId IdType="pubmed">27545679</ArticleId></ArticleIdList></Reference><Reference><Citation>Duis J., Dean S., Applegate C., Harper A., Xiao R., He W., Dollar J.D., Sun L.R., Waberski M.B., Crawford T.O., et al. KIF5A mutations cause an infantile onset phenotype including severe myoclonus with evidence of mitochondrial dysfunction. Ann. Neurol. 2016;80:633&#x2013;637. doi: 10.1002/ana.24744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24744</ArticleId><ArticleId IdType="pmc">PMC5042851</ArticleId><ArticleId IdType="pubmed">27463701</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydzanicz M., Jag&#x142;a M., Kosinska J., Tomasik T., Sobczak A., Pollak A., Herman-Sucharska I., Walczak A., Kwinta P., P&#x142;oski R. KIF5A de novo mutation associated with myoclonic seizures and neonatal onset progressive leukoencephalopathy. Clin. Genet. 2017;91:769&#x2013;773. doi: 10.1111/cge.12831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.12831</ArticleId><ArticleId IdType="pubmed">27414745</ArticleId></ArticleIdList></Reference><Reference><Citation>Huai J., Zhang Z. Structural Properties and Interaction Partners of Familial ALS-Associated SOD1 Mutants. Front. Neurol. 2019;10:527. doi: 10.3389/fneur.2019.00527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00527</ArticleId><ArticleId IdType="pmc">PMC6536575</ArticleId><ArticleId IdType="pubmed">31164862</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon R.A., Bunton-Stasyshyn R.K.A., Fisher E.M.C., Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain. 2013;136:2342&#x2013;2358. doi: 10.1093/brain/awt097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt097</ArticleId><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.H., Elpers C., Reunert J., McCormick M.L., Mohr J., Biskup S., Schwartz O., Rust S., Gr&#xfc;neberg M., Seelh&#xf6;fer A., et al. SOD1 deficiency: A novel syndrome distinct from amyotrophic lateral sclerosis. Brain. 2019;142:2230&#x2013;2237. doi: 10.1093/brain/awz182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz182</ArticleId><ArticleId IdType="pmc">PMC6658856</ArticleId><ArticleId IdType="pubmed">31332433</ArticleId></ArticleIdList></Reference><Reference><Citation>Roczniak-Ferguson A., Ferguson S.M. Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis. Life Sci. Alliance. 2019;2:e201900358. doi: 10.26508/lsa.201900358.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201900358</ArticleId><ArticleId IdType="pmc">PMC6749094</ArticleId><ArticleId IdType="pubmed">31527135</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H., Valdmanis P.N., Kabashi E., Dion P., Dupre N., Camu W., Meininger V., Rouleau G.A. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J. Med. Genet. 2008;46:112&#x2013;114. doi: 10.1136/jmg.2008.062463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2008.062463</ArticleId><ArticleId IdType="pubmed">18931000</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Rouleau G.A., Kabashi E. TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update. Hum. Mutat. 2013;34:812&#x2013;826. doi: 10.1002/humu.22319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22319</ArticleId><ArticleId IdType="pubmed">23559573</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H., Gao K., Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 2014;10:337&#x2013;348. doi: 10.1038/nrneurol.2014.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.78</ArticleId><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>An H., Rabesahala de Meritens C., Buchman V.L., Shelkovnikova T.A. Frameshift peptides alter the properties of truncated FUS proteins in ALS-FUS. Mol. Brain. 2020;13:77. doi: 10.1186/s13041-020-00618-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-00618-0</ArticleId><ArticleId IdType="pmc">PMC7222445</ArticleId><ArticleId IdType="pubmed">32404191</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Peikert K., G&#xfc;nther R., Kooi A.J., Aronica E., H&#xfc;bers A., Danel V., Corcia P., Pan-Montojo F., Cirak S., et al. Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2019;6:2384&#x2013;2394. doi: 10.1002/acn3.50930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50930</ArticleId><ArticleId IdType="pmc">PMC6917314</ArticleId><ArticleId IdType="pubmed">31682085</ArticleId></ArticleIdList></Reference><Reference><Citation>Merner N.D., Girard S.L., Catoire H., Bourassa C.V., Belzil V.V., Rivi&#xe8;re J.-B., Hince P., Levert A., Dionne-Laporte A., Spiegelman D., et al. Exome Sequencing Identifies FUS Mutations as a Cause of Essential Tremor. Am. J. Hum. Genet. 2012;91:313&#x2013;319. doi: 10.1016/j.ajhg.2012.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.07.002</ArticleId><ArticleId IdType="pmc">PMC3415547</ArticleId><ArticleId IdType="pubmed">22863194</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S., Hand C.K., Osuga H., Yanagisawa Y., Otomo A., Devon R.S., Miyamoto N., Showguchi-Miyata J., Okada Y., Singaraja R., et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 2001;29:166&#x2013;173. doi: 10.1038/ng1001-166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1001-166</ArticleId><ArticleId IdType="pubmed">11586298</ArticleId></ArticleIdList></Reference><Reference><Citation>Eilbeck K., Quinlan A., Yandell M. Settling the score: Variant prioritization and Mendelian disease. Nat. Rev. Genet. 2017;18:599&#x2013;612. doi: 10.1038/nrg.2017.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg.2017.52</ArticleId><ArticleId IdType="pmc">PMC5935497</ArticleId><ArticleId IdType="pubmed">28804138</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., zheng Z.-Z., Huang R., Chen K., Song W., Zhao B., Chen X., Yang Y., Yuan L., Shang H.-F. PFN1 mutations are rare in Han Chinese populations with amyotrophic lateral sclerosis. Neurobiol. Aging. 2013;34:1922.e1&#x2013;1922.e5. doi: 10.1016/j.neurobiolaging.2013.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.01.013</ArticleId><ArticleId IdType="pubmed">23428184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan M.S., Shaalan A.A., Dessouky M.I., Abdelnaiem A.E., ElHefnawi M. A review study: Computational techniques for expecting the impact of non-synonymous single nucleotide variants in human diseases. Gene. 2019;680:20&#x2013;33. doi: 10.1016/j.gene.2018.09.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.09.028</ArticleId><ArticleId IdType="pubmed">30240882</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.-J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Conforti F.L., Spataro R., Sproviero W., Mazzei R., Cavalcanti F., Condino F., Simone I.L., Logroscino G., Patitucci A., Magariello A., et al. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology. 2012;79:2315&#x2013;2320. doi: 10.1212/WNL.0b013e318278b618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318278b618</ArticleId><ArticleId IdType="pubmed">23197749</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuenschwander A.G., Thai K.K., Figueroa K.P., Pulst S.M. Amyotrophic Lateral Sclerosis Risk for Spinocerebellar Ataxia Type 2 ATXN2 CAG Repeat Alleles. JAMA Neurol. 2014;71:1529. doi: 10.1001/jamaneurol.2014.2082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.2082</ArticleId><ArticleId IdType="pmc">PMC4939089</ArticleId><ArticleId IdType="pubmed">25285812</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., Mullen B., Heckman M.G., Baker M.C., DeJesus-Hernandez M., Brown P.H., Murray M.E., Hsiung G.-Y.R., Stewart H., Karydas A.M., et al. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiol. Aging. 2014;35:2421.e13&#x2013;2421.e17. doi: 10.1016/j.neurobiolaging.2014.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.04.016</ArticleId><ArticleId IdType="pmc">PMC4105839</ArticleId><ArticleId IdType="pubmed">24866401</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Calvo A., Moglia C., Canosa A., Brunetti M., Barberis M., Restagno G., Conte A., Bisogni G., Marangi G., et al. ATXN2 polyQ intermediate repeats are a modifier of ALS survival. Neurology. 2015;84:251&#x2013;258. doi: 10.1212/WNL.0000000000001159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001159</ArticleId><ArticleId IdType="pubmed">25527265</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Kocerha J., Finch N., Crook R., Baker M., Desaro P., Johnston A., Rutherford N., Wojtas A., Kennelly K., et al. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum. Mutat. 2010;31:E1377&#x2013;E1389. doi: 10.1002/humu.21241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21241</ArticleId><ArticleId IdType="pmc">PMC2922682</ArticleId><ArticleId IdType="pubmed">20232451</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A., Moglia C., Canosa A., Brunetti M., Barberis M., Traynor B.J., Carrara G., Valentini C., Restagno G., Chi&#xf2; A. A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. Neurobiol. Aging. 2014;35:1513.e7&#x2013;1513.e11. doi: 10.1016/j.neurobiolaging.2013.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.12.028</ArticleId><ArticleId IdType="pmc">PMC3961545</ArticleId><ArticleId IdType="pubmed">24439481</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte A., Lattante S., Zollino M., Marangi G., Luigetti M., Del Grande A., Servidei S., Trombetta F., Sabatelli M. P525L FUS mutation is consistently associated with a severe form of juvenile Amyotrophic Lateral Sclerosis. Neuromuscul. Disord. 2012;22:73&#x2013;75. doi: 10.1016/j.nmd.2011.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2011.08.003</ArticleId><ArticleId IdType="pubmed">21907581</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.-Y., Cui L.-Y., Sun Q., Li X.-G., Liu M.-S., Xu Y., Zhou Y., Yang X.-Z. De novo FUS gene mutations are associated with juvenile-onset sporadic amyotrophic lateral sclerosis in China. Neurobiol. Aging. 2013;34:1312.e1&#x2013;1312.e8. doi: 10.1016/j.neurobiolaging.2012.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.09.005</ArticleId><ArticleId IdType="pubmed">23046859</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.-E., Oh K.-W., Kwon M.-J., Choi W.-J., Oh S., Ki C.-S., Kim S.H. De novo FUS mutations in 2 Korean patients with sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36:1604.e17&#x2013;1604.e19. doi: 10.1016/j.neurobiolaging.2014.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.10.002</ArticleId><ArticleId IdType="pubmed">25457557</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;bers A., Just W., Rosenbohm A., M&#xfc;ller K., Marroquin N., Goebel I., H&#xf6;gel J., Thiele H., Altm&#xfc;ller J., N&#xfc;rnberg P., et al. De novo FUS mutations are the most frequent genetic cause in early-onset German ALS patients. Neurobiol. Aging. 2015;36:3117.e1&#x2013;3117.e6. doi: 10.1016/j.neurobiolaging.2015.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.08.005</ArticleId><ArticleId IdType="pubmed">26362943</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond C.S., Webber A., Gan-Or Z., Moore F., Dagher A., Dion P.A., Rouleau G.A. De novo FUS P525L mutation in Juvenile amyotrophic lateral sclerosis with dysphonia and diplopia. Neurol. Genet. 2016;2:e63. doi: 10.1212/NXG.0000000000000063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000063</ArticleId><ArticleId IdType="pmc">PMC4830191</ArticleId><ArticleId IdType="pubmed">27123482</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Wang H., Cai Y., Wen H., Wang L., Zhu M., Chen Y., Yu Y., Lu X., Zhou M., et al. FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders. Brain Behav. 2020;10:e01625. doi: 10.1002/brb3.1625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1625</ArticleId><ArticleId IdType="pmc">PMC7303404</ArticleId><ArticleId IdType="pubmed">32307925</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Li J., Lu H., Liu Y. A de novo c.1509dupA:p.R503fs mutation of FUS: Report of a girl with sporadic juvenile amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2020;5:1&#x2013;3. doi: 10.1080/21678421.2020.1775256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1775256</ArticleId><ArticleId IdType="pubmed">32501131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S.M., Kim Y.-E., Choi W.J., Oh K.-W., Noh M.-Y., Kwon M.-S., Nahm M., Kim N., Ki C.-S., Kim S.H. CLEC4C p.K210del variant causes impaired cell surface transport in plasmacytoid dendritic cells of amyotrophic lateral sclerosis. Oncotarget. 2016;7:24942&#x2013;24949. doi: 10.18632/oncotarget.7886.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.7886</ArticleId><ArticleId IdType="pmc">PMC5041881</ArticleId><ArticleId IdType="pubmed">26943047</ArticleId></ArticleIdList></Reference><Reference><Citation>van Doormaal P.T.C., Ticozzi N., Weishaupt J.H., Kenna K., Diekstra F.P., Verde F., Andersen P.M., Dekker A.M., Tiloca C., Marroquin N., et al. The role of de novo mutations in the development of amyotrophic lateral sclerosis. Hum. Mutat. 2017;38:1534&#x2013;1541. doi: 10.1002/humu.23295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23295</ArticleId><ArticleId IdType="pmc">PMC6599399</ArticleId><ArticleId IdType="pubmed">28714244</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., van den Berg L.H., Veldink J. Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nat. Rev. Neurol. 2017;13:96&#x2013;104. doi: 10.1038/nrneurol.2016.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiffin N., Minikel E., Walsh R., O&#x2019;Donnell-Luria A.H., Karczewski K., Ing A.Y., Barton P.J.R., Funke B., Cook S.A., MacArthur D., et al. Using high-resolution variant frequencies to empower clinical genome interpretation. Genet. Med. 2017;19:1151&#x2013;1158. doi: 10.1038/gim.2017.26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2017.26</ArticleId><ArticleId IdType="pmc">PMC5563454</ArticleId><ArticleId IdType="pubmed">28518168</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston C.A., Stanton B.R., Turner M.R., Gray R., Blunt A.H.-M., Butt D., Ampong M.-A., Shaw C.E., Leigh P.N., Al-Chalabi A. Amyotrophic lateral sclerosis in an urban setting. J. Neurol. 2006;253:1642&#x2013;1643. doi: 10.1007/s00415-006-0195-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-006-0195-y</ArticleId><ArticleId IdType="pubmed">17219036</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy N.A., Arthur K.C., Tienari P.J., Houlden H., Chi&#xf2; A., Traynor B.J. Age-related penetrance of the C9orf72 repeat expansion. Sci. Rep. 2017;7:2116. doi: 10.1038/s41598-017-02364-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-02364-1</ArticleId><ArticleId IdType="pmc">PMC5437033</ArticleId><ArticleId IdType="pubmed">28522837</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A. Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: Evidence for a linked protective factor. Hum. Mol. Genet. 1998;7:2045&#x2013;2050. doi: 10.1093/hmg/7.13.2045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/7.13.2045</ArticleId><ArticleId IdType="pubmed">9817920</ArticleId></ArticleIdList></Reference><Reference><Citation>Project MinE ALS Sequencing Consortium Project MinE: Study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur. J. Hum. Genet. 2018;26:1537&#x2013;1546. doi: 10.1038/s41431-018-0177-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0177-4</ArticleId><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>Felbecker A., Camu W., Valdmanis P.N., Sperfeld A.D., Waibel S., Steinbach P., Rouleau G.A., Ludolph A.C., Andersen P.M. Four familial ALS pedigrees discordant for two SOD1 mutations: Are all SOD1 mutations pathogenic? J. Neurol. Neurosurg. Psychiatry. 2010;81:572&#x2013;577. doi: 10.1136/jnnp.2009.192310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.192310</ArticleId><ArticleId IdType="pubmed">20460594</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezania K., Yan J., Dellefave L., Deng H., Siddique N., Pascuzzi R.T., Siddique T., Roos R.P. A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset, incomplete penetrance and a sensory neuropathy. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2003;4:162&#x2013;166. doi: 10.1080/aml.4.3.162.166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/aml.4.3.162.166</ArticleId><ArticleId IdType="pubmed">13129803</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogales-Gadea G., Garcia-Arumi E., Andreu A.L., Cervera C., Gamez J. A novel exon 5 mutation (N139H) in the SOD1 gene in a Spanish family associated with incomplete penetrance. J. Neurol. Sci. 2004;219:1&#x2013;6. doi: 10.1016/j.jns.2003.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2003.10.018</ArticleId><ArticleId IdType="pubmed">15050430</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamez J., Caponnetto C., Ferrera L., Syriani E., Marini V., Morales M., Bordo D., Pirro C., Garre C., Origone P. I112M SOD1 mutation causes ALS with rapid progression and reduced penetrance in four Mediterranean families. Amyotroph. Lateral Scler. 2011;12:70&#x2013;75. doi: 10.3109/17482968.2010.487906.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.487906</ArticleId><ArticleId IdType="pubmed">20515426</ArticleId></ArticleIdList></Reference><Reference><Citation>Conforti F.L., Barone R., Fermo S.L., Giliberto C., Patti F., Gambardella A., Quattrone A., Zappia M. Sporadic motor neuron disease in a familial novel SOD1 mutation: Incomplete penetrance or chance association? Amyotroph. Lateral Scler. 2011;12:220&#x2013;222. doi: 10.3109/17482968.2010.545951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.545951</ArticleId><ArticleId IdType="pubmed">21545237</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida A., Sasaguri H., Kimura N., Tajiri M., Ohkubo T., Ono F., Sakaue F., Kanai K., Hirai T., Sano T., et al. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain. 2012;135:833&#x2013;846. doi: 10.1093/brain/awr348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr348</ArticleId><ArticleId IdType="pmc">PMC3286326</ArticleId><ArticleId IdType="pubmed">22252998</ArticleId></ArticleIdList></Reference><Reference><Citation>Crociara P., Chieppa M.N., Vallino Costassa E., Berrone E., Gallo M., Lo Faro M., Pintore M.D., Iulini B., D&#x2019;Angelo A., Perona G., et al. Motor neuron degeneration, severe myopathy and TDP-43 increase in a transgenic pig model of SOD1-linked familiar ALS. Neurobiol. Dis. 2019;124:263&#x2013;275. doi: 10.1016/j.nbd.2018.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.11.021</ArticleId><ArticleId IdType="pubmed">30471417</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Robberecht W., Van Den Bosch L. Modelling amyotrophic lateral sclerosis: Progress and possibilities. Dis. Model. Mech. 2017;10:537&#x2013;549. doi: 10.1242/dmm.029058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029058</ArticleId><ArticleId IdType="pmc">PMC5451175</ArticleId><ArticleId IdType="pubmed">28468939</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrice J., Gregory-Evans C., Shaw C. Animal models of amyotrophic lateral sclerosis: A comparison of model validity. Neural Regen. Res. 2018;13:2050. doi: 10.4103/1673-5374.241445.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.241445</ArticleId><ArticleId IdType="pmc">PMC6199948</ArticleId><ArticleId IdType="pubmed">30323119</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi L., Valenza F., Mosca L., Dal Mas A., Domi T., Romano A., Tarlarini C., Falzone Y.M., Tremolizzo L., Sorar&#xf9; G., et al. TBK1 mutations in Italian patients with amyotrophic lateral sclerosis: Genetic and functional characterisation. J. Neurol. Neurosurg. Psychiatry. 2017;88:869&#x2013;875. doi: 10.1136/jnnp-2017-316174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316174</ArticleId><ArticleId IdType="pmc">PMC5629935</ArticleId><ArticleId IdType="pubmed">28822984</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Doronzio P.N., Marangi G., Conte A., Bisogni G., Bernardo D., Russo T., Lamberti D., Patrizi S., Apollo F.P., et al. Coexistence of variants in TBK1 and in other ALS-related genes elucidates an oligogenic model of pathogenesis in sporadic ALS. Neurobiol. Aging. 2019;84:239.e9&#x2013;239.e14. doi: 10.1016/j.neurobiolaging.2019.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.03.010</ArticleId><ArticleId IdType="pubmed">31000212</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Hardiman O. The epidemiology of ALS: A conspiracy of genes, environment and time. Nat. Rev. Neurol. 2013;9:617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzoni V. Amyotrophic lateral sclerosis and environmental factors. Funct. Neurol. 2016;31:7&#x2013;19. doi: 10.11138/FNeur/2016.31.1.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.11138/FNeur/2016.31.1.007</ArticleId><ArticleId IdType="pmc">PMC4819821</ArticleId><ArticleId IdType="pubmed">27027889</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Fang F., Hanby M.F., Leigh P.N., Shaw C.E., Ye W., Rijsdijk F. An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry. 2010;81:1324&#x2013;1326. doi: 10.1136/jnnp.2010.207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller M.F., Ferrucci L., Singleton A.B., Tienari P.J., Laaksovirta H., Restagno G., Chi&#xf2; A., Traynor B.J., Nalls M.A. Genome-Wide Analysis of the Heritability of Amyotrophic Lateral Sclerosis. JAMA Neurol. 2014;71:1123. doi: 10.1001/jamaneurol.2014.1184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1184</ArticleId><ArticleId IdType="pmc">PMC4566960</ArticleId><ArticleId IdType="pubmed">25023141</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh I., Ratti A., Gellera C., Lin K., Tiloca C., Moskvina V., Corrado L., Soraru G., Cereda C., Corti S., et al. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 2014;23:2220&#x2013;2231. doi: 10.1093/hmg/ddt587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt587</ArticleId><ArticleId IdType="pmc">PMC3959809</ArticleId><ArticleId IdType="pubmed">24256812</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M., Heverin M., McLaughlin R.L., Hardiman O. Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis. JAMA Neurol. 2019;76:1367. doi: 10.1001/jamaneurol.2019.2044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2044</ArticleId><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747&#x2013;753. doi: 10.1038/nature08494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08494</ArticleId><ArticleId IdType="pmc">PMC2831613</ArticleId><ArticleId IdType="pubmed">19812666</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley M.D., Thomas A., Gitler A.D. Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis. Neurobiol. Aging. 2014;35:936.e1&#x2013;936.e4. doi: 10.1016/j.neurobiolaging.2013.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.09.024</ArticleId><ArticleId IdType="pmc">PMC3880650</ArticleId><ArticleId IdType="pubmed">24269018</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulson H. The Handbook of Clinical Neurology. Volume 147. Elsevier; Amsterdam, The Netherlands: 2018. Repeat expansion diseases; pp. 105&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63233-3.00009-9</ArticleId><ArticleId IdType="pmc">PMC6485936</ArticleId><ArticleId IdType="pubmed">29325606</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefian-Jazi A., Sung M.K., Lee T., Hong Y.-H., Choi J.K., Choi J. Functional fine-mapping of noncoding risk variants in amyotrophic lateral sclerosis utilizing convolutional neural network. Sci. Rep. 2020;10:12872. doi: 10.1038/s41598-020-69790-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-69790-6</ArticleId><ArticleId IdType="pmc">PMC7393092</ArticleId><ArticleId IdType="pubmed">32732921</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S., Shatunov A., Sproviero W., Jones A.R., Shoai M., Hughes D., Al Khleifat A., Malaspina A., Morrison K.E., Shaw P.J., et al. A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK. Brain. 2017;140:1611&#x2013;1618. doi: 10.1093/brain/awx082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx082</ArticleId><ArticleId IdType="pmc">PMC5445258</ArticleId><ArticleId IdType="pubmed">28430856</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunissen F., Flynn L.L., Anderton R.S., Mastaglia F., Pytte J., Jiang L., Hodgetts S., Burns D.K., Saunders A., Fletcher S., et al. Structural Variants May Be a Source of Missing Heritability in sALS. Front. Neurosci. 2020;14:47. doi: 10.3389/fnins.2020.00047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00047</ArticleId><ArticleId IdType="pmc">PMC7005198</ArticleId><ArticleId IdType="pubmed">32082115</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., van Es M.A., Hennekam E.A.M., Dooijes D., van Rheenen W., Medic J., Bourque P.R., Schelhaas H.J., van der Kooi A.J., de Visser M., et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012;21:3776&#x2013;3784. doi: 10.1093/hmg/dds199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds199</ArticleId><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna K.P., McLaughlin R.L., Byrne S., Elamin M., Heverin M., Kenny E.M., Cormican P., Morris D.W., Donaghy C.G., Bradley D.G., et al. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J. Med. Genet. 2013;50:776&#x2013;783. doi: 10.1136/jmedgenet-2013-101795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2013-101795</ArticleId><ArticleId IdType="pmc">PMC3812897</ArticleId><ArticleId IdType="pubmed">23881933</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Robins H., Niedermoser I., Wyles M., Heath P.R., Higginbottom A., Walsh T., Kazoka M., Ince P.G., Hautbergue G.M., et al. Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical Phenotype. Front. Mol. Neurosci. 2017;10:370. doi: 10.3389/fnmol.2017.00370.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00370</ArticleId><ArticleId IdType="pmc">PMC5684183</ArticleId><ArticleId IdType="pubmed">29170628</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady J., Allred P., Bali T., Pestronk A., Goate A., Miller T.M., Mitra R.D., Ravits J., Harms M.B., Baloh R.H. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann. Neurol. 2015;77:100&#x2013;113. doi: 10.1002/ana.24306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24306</ArticleId><ArticleId IdType="pmc">PMC4293318</ArticleId><ArticleId IdType="pubmed">25382069</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H., Ishiura H., Mitsui J., Takahashi Y., Matsukawa T., Tanaka M., Doi K., Yoshimura J., Morishita S., Goto J., et al. Burden of rare variants in causative genes for amyotrophic lateral sclerosis (ALS) accelerates age at onset of ALS. J. Neurol. Neurosurg. Psychiatry. 2019;90:537&#x2013;542. doi: 10.1136/jnnp-2018-318568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318568</ArticleId><ArticleId IdType="pubmed">30355605</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang S.Y.-Y., Hsu J.S., Teo K.-C., Li Y., Kung M.H.W., Cheah K.S.E., Chan D., Cheung K.M.C., Li M., Sham P.-C., et al. Burden of rare variants in ALS genes influences survival in familial and sporadic ALS. Neurobiol. Aging. 2017;58:238.e9&#x2013;238.e15. doi: 10.1016/j.neurobiolaging.2017.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.06.007</ArticleId><ArticleId IdType="pubmed">28709720</ArticleId></ArticleIdList></Reference><Reference><Citation>Leija-Salazar M., Piette C., Proukakis C. Review: Somatic mutations in neurodegeneration. Neuropathol. Appl. Neurobiol. 2018;44:267&#x2013;285. doi: 10.1111/nan.12465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12465</ArticleId><ArticleId IdType="pubmed">29369391</ArticleId></ArticleIdList></Reference><Reference><Citation>Proukakis C. Somatic mutations in neurodegeneration: An update. Neurobiol. Dis. 2020;144:105021. doi: 10.1016/j.nbd.2020.105021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105021</ArticleId><ArticleId IdType="pubmed">32712267</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A., Logroscino G., Hernan M.A. Smoking and the risk of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2010;81:1249&#x2013;1252. doi: 10.1136/jnnp.2009.180232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.180232</ArticleId><ArticleId IdType="pubmed">20639382</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Richard M., Sandler D.P., Umbach D.M., Kamel F. Head Injury and Amyotrophic Lateral Sclerosis. Am. J. Epidemiol. 2007;166:810&#x2013;816. doi: 10.1093/aje/kwm153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwm153</ArticleId><ArticleId IdType="pmc">PMC2239342</ArticleId><ArticleId IdType="pubmed">17641152</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Lee M.-H., Henderson L., Tyagi R., Bachani M., Steiner J., Campanac E., Hoffman D.A., von Geldern G., Johnson K., et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci. Transl. Med. 2015;7:307ra153. doi: 10.1126/scitranslmed.aac8201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aac8201</ArticleId><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B., Horton D.K., Mitsumoto H. Potential Environmental Factors in Amyotrophic Lateral Sclerosis. Neurol. Clin. 2015;33:877&#x2013;888. doi: 10.1016/j.ncl.2015.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.009</ArticleId><ArticleId IdType="pmc">PMC4646848</ArticleId><ArticleId IdType="pubmed">26515627</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Calvo A., Chio A., Colville S., Ellis C.M., Hardiman O., Heverin M., Howard R.S., Huisman M.H.B., Keren N., et al. Analysis of amyotrophic lateral sclerosis as a multistep process: A population-based modelling study. Lancet Neurol. 2014;13:1108&#x2013;1113. doi: 10.1016/S1474-4422(14)70219-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Mazzini L., D&#x2019;Alfonso S., Corrado L., Canosa A., Moglia C., Manera U., Bersano E., Brunetti M., Barberis M., et al. The multistep hypothesis of ALS revisited. Neurology. 2018;91:e635&#x2013;e642. doi: 10.1212/WNL.0000000000005996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005996</ArticleId><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S., Higashihara M., Sobue G., Atsuta N., Doi Y., Kuwabara S., Kim S.H., Kim I., Oh K.-W., Park J., et al. ALS is a multistep process in South Korean, Japanese, and Australian patients. Neurology. 2020;94:e1657&#x2013;e1663. doi: 10.1212/WNL.0000000000009015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009015</ArticleId><ArticleId IdType="pmc">PMC7251515</ArticleId><ArticleId IdType="pubmed">32071166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross J.P., Leblond C.S., Laurent S.B., Spiegelman D., Dionne-Laporte A., Camu W., Dupr&#xe9; N., Dion P.A., Rouleau G.A. Oligogenicity, C9orf72 expansion, and variant severity in ALS. Neurogenetics. 2020;21:227&#x2013;242. doi: 10.1007/s10048-020-00612-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-020-00612-7</ArticleId><ArticleId IdType="pubmed">32385536</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.P., Van Broeckhoven C., van der Zee J. ALS Genes in the Genomic Era and their Implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuuluvainen L., Kaivola K., M&#xf6;nk&#xe4;re S., Laaksovirta H., Jokela M., Udd B., Valori M., Pasanen P., Paetau A., Traynor B.J., et al. Oligogenic basis of sporadic ALS. Neurol. Genet. 2019;5:e335. doi: 10.1212/NXG.0000000000000335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000335</ArticleId><ArticleId IdType="pmc">PMC6481226</ArticleId><ArticleId IdType="pubmed">31086828</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann E.P., Henden L., Fifita J.A., Zhang K.Y., Grima N., Bauer D.C., Chan Moi Fat S., Twine N.A., Pamphlett R., Kiernan M.C., et al. Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis; jmedgenet-2020. J. Med. Genet. 2020:1&#x2013;9. doi: 10.1136/jmedgenet-2020-106866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2020-106866</ArticleId><ArticleId IdType="pubmed">32409511</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarlino S., Domi T., Pozzi L., Romano A., Pipitone G.B., Falzone Y.M., Mosca L., Penco S., Lunetta C., Sansone V., et al. Burden of Rare Variants in ALS and Axonal Hereditary Neuropathy Genes Influence Survival in ALS: Insights from a Next Generation Sequencing Study of an Italian ALS Cohort. Int. J. Mol. Sci. 2020;21:3346. doi: 10.3390/ijms21093346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21093346</ArticleId><ArticleId IdType="pmc">PMC7246633</ArticleId><ArticleId IdType="pubmed">32397312</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>